Spinal Lamina II Neurons

📖 Wiki Page

cell1120 wordssynced 2026-04-02

Spinal Lamina II (Substantia Gelatinosa) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Spinal Lamina II Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">GAD67</td>
<td>High</td>
</tr>
<tr>
<td class="label">VGLUT2</td>
<td>High</td>
</tr>
<tr>
<td class="label">PKCγ</td>
<td>Subset</td>
</tr>
<tr>
<td class="label">Calretinin</td>
<td>Subset</td>
</tr>
<tr>
<td class="label">NPY</td>
<td>Subset</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Gabapentinoids (gabapentin, pregabalin)</td>
<td>Bind to α2δ subunit of voltage-gated calcium channels</td>
</tr>
<tr>
<td class="label">Opioids</td>
<td>Activate μ-opioid receptors on interneurons</td>
</tr>
<tr>
<td class="label">Baclofen</td>
<td>GABA-B receptor agonist</td>
</tr>
<tr>
<td class="label">SSRI/SNRIs</td>
<td>Enhance descending inhibition</td>
</tr>
</table>

Overview

...

Spinal Lamina II (Substantia Gelatinosa) Neurons

Overview

Mermaid diagram (expand to render)

Spinal Lamina Ii [Neurons](/entities/neurons) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Introduction

Spinal Lamina II neurons, also known as the Substantia Gelatinosa, constitute a critical processing center within the dorsal horn of the spinal cord. These neurons play a fundamental role in modulating nociceptive (pain) transmission, sensory gating, and are increasingly recognized for their involvement in neurodegenerative disease processes affecting the central nervous system. [@todd2010]

Anatomical Organization

Location and Structure

Lamina II is situated in the superficial dorsal horn of the spinal cord, immediately dorsal to Lamina III. The region is characterized by a dense network of interneurons and glial cells, with a distinctive gelatinous appearance due to its high density of neuropil and relatively low cell body density. The substantia gelatinosa extends throughout the rostrocaudal axis of the spinal cord, with the highest concentration in cervical and lumbar enlargements corresponding to upper and lower limb innervation. [@kuner2010]

Cellular Composition

The Lamina II neuronal population consists primarily of: [@latremoliere2009]

GABAergic interneurons (approximately 30-40%): Use gamma-aminobutyric acid (GABA) as the primary inhibitory neurotransmitter
Glutamatergic interneurons (approximately 50-60%): Use glutamate for excitatory transmission
Glycinergic neurons: Co-localize with GABA in some populations
Peptidergic neurons: Express neuropeptides such as substance P, calcitonin gene-related peptide (CGRP), and somatostatin

Key Molecular Markers

Normal Physiological Functions

Nociceptive Processing

Lamina II serves as the primary gateway for processing nociceptive (pain) information from peripheral nociceptors. The region receives input from Aδ and C fiber primary afferents that carry information about potentially tissue-damaging stimuli. Within Lamina II, these inputs undergo significant processing through complex synaptic interactions between excitatory and inhibitory interneurons.

The neuronal circuits within Lamina II perform several critical functions:

Signal Integration: Convergence of multiple sensory inputs allows for spatial and temporal integration of pain signals

Modulation: Inhibitory interneurons provide presynaptic and postsynaptic inhibition to modulate pain transmission

Gate Control: The balance between excitatory and inhibitory signaling determines whether pain signals propagate to supraspinal centers

Plasticity: Activity-dependent changes in synaptic strength allow for sensitization and habituation phenomena

Pain Gating Mechanisms

The substantia gelatinosa implements a "gate control" mechanism whereby:

Low-intensity, non-noxious input ([Aβ](/proteins/amyloid-beta) fibers) can activate inhibitory interneurons
This inhibition suppresses the transmission of higher-intensity nociceptive signals
The net effect is selective filtering of sensory information

Itch Processing

Emerging evidence indicates Lamina II neurons also participate in itch sensation. Specific populations of interneurons expressing gastrin-releasing peptide (GRP) and its receptor (GRPR) are implicated in itch signaling, demonstrating the complex multiplexing of sensory modalities within this region.

Role in Neurodegenerative Diseases

Alzheimer's Disease

While Lamina II is not traditionally considered a primary focus of [Alzheimer's disease](/diseases/alzheimers-disease) (AD) pathology, emerging research suggests several connections:

Cholinergic modulation: Loss of basal forebrain cholinergic neurons in AD may disrupt the cholinergic modulation of dorsal horn pain circuits, potentially contributing to altered pain perception in AD patients
Neuroinflammation: Systemic inflammation in AD may affect Lamina II neuronal function
Pain perception changes: Clinical observations indicate altered pain thresholds and increased pain sensitivity in AD patients, possibly involving dysregulated sensory processing

Parkinson's Disease

Lamina II involvement in [Parkinson's disease](/diseases/parkinsons-disease-disease) (PD) relates to:

[Alpha-synuclein](/proteins/alpha-synuclein) pathology: While primarily affecting subcortical structures, PD pathology may extend to spinal cord regions
Pain comorbidities: Up to 50-80% of PD patients experience pain, often with neuropathic characteristics
Dopaminergic modulation: Dopaminergic projections from the ventrolateral periaqueductal gray modulate dorsal horn pain circuits, and these may be affected in PD

Amyotrophic Lateral Sclerosis (ALS)

Lamina II may be affected in ALS through:

Motor neuron degeneration: While primarily affecting upper and lower motor neurons, ALS may involve propriospinal neurons that interconnect with Lamina II
Sensory involvement: Some ALS patients experience sensory symptoms, potentially involving dorsal horn circuits

Chronic Pain in Neurodegeneration

A key intersection between neurodegenerative diseases and Lamina II function is the development of chronic pain:

Central sensitization: Prolonged nociceptive input can lead to maladaptive plasticity in Lamina II, resulting in chronic pain states
Loss of inhibition: Neurodegenerative processes may selectively affect inhibitory interneurons, reducing pain gating capacity
Glial activation: Activated [microglia](/entities/microglia) and [astrocytes](/entities/astrocytes) in the dorsal horn contribute to pain hypersensitization

Therapeutic Implications

Pharmacological Targets

Several drug classes target Lamina II circuitry:

Neuromodulation Approaches

Spinal cord stimulation: Activates dorsal horn circuits including Lamina II
Dorsal root ganglion stimulation: Modulates primary afferent input
Transcranial magnetic stimulation: May affect descending pain modulatory systems

Emerging Therapies

Gene therapy: Targeted delivery of analgesic peptides
Cell therapy: Transplantation of GABAergic interneuron progenitors
Optogenetics: Precise control of specific neuronal populations

Research Models

Animal Models

Rodent models: Extensive characterization of rodent Lamina II circuitry
Transgenic models: Mice lacking specific interneuron populations
lesion models: Selective ablation of inhibitory neurons

In Vitro Systems

Organotypic slice cultures: Maintain dorsal horn circuitry
iPSC-derived neurons: Patient-specific models
Microfluidic devices: Compartmentalized neuron cultures

External Links

[Spinal Cord Dorsal Horn - Nature Reviews Neuroscience](https://www.nature.com/articles/nrn2459)
[Pain Processing in Spinal Cord - Brain](https://academic.oup.com/brain)
[NIH Pain Research](https://www.ninds.nih.gov/ pain-research)

Overview

Spinal Lamina Ii Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Spinal Lamina Ii Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Spinal Lamina II Neurons discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Spinal Lamina II Neurons

Spinal Lamina II (Substantia Gelatinosa) Neurons

Overview

Spinal Lamina II (Substantia Gelatinosa) Neurons

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

Introduction

Anatomical Organization

Location and Structure

Cellular Composition

Key Molecular Markers

Normal Physiological Functions

Nociceptive Processing

Pain Gating Mechanisms

Itch Processing

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Chronic Pain in Neurodegeneration

Therapeutic Implications

Pharmacological Targets

Neuromodulation Approaches

Emerging Therapies

Research Models

Animal Models

In Vitro Systems

See Also

External Links

Overview

Background

Pathway Diagram